Nalaganje...
Systemic therapy for bladder cancer – a medical oncologist’s perspective
Advanced bladder cancer, both muscle-invasive localized disease and metastatic disease, is managed with systemic chemotherapy. Cisplatin-based multi-agent chemotherapy remains the cornerstone for systemic therapy. MVAC (methotrexate-vinblastine-doxorubicin-cisplatin) has been most rigorously studied...
Shranjeno v:
| izdano v: | J Solid Tumors |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4232954/ https://ncbi.nlm.nih.gov/pubmed/25404954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5430/jst.v4n2p25 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|